FRONT ONCOL 润色咨询

Frontiers in Oncology

出版年份:暂无数据 年文章数:1435 投稿命中率:55.07%

出版周期:Irregular 自引率:2.1% 审稿周期:平均3.22月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均3.22月 (网友贡献,非官方数据)
投稿命中率
55.07% (网友贡献,非官方数据)
审稿费用
0.0元/篇 (网友贡献,非官方数据)
版面费用
2949.17元/篇 (网友贡献,非官方数据)
中国人发表比例
2019年中国人文章占该期刊总数量40.63% (2018年为13.23%)
自引率
2.1 %
年文章数
1435
期刊官网
点击查看 (点击次数:14269)
点击查看 (点击次数:10038次)
作者需知
点击查看 (点击次数:1458次)
期刊简介
稿件收录要求

Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.

Field Chief Editor Giuseppe Giaccone at Weill Cornell Medicine, Cornell University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific advancement and impactful discoveries on the field of oncology to researchers, academics, clinicians, and the public worldwide..

Frontiers in Oncology welcomes contributions in the various domains of cancer research, from basic research to clinical studies. The journal is composed of different specialty sections and authors are kindly requested to consider the specific requirements of the most adequate specialty for their submission.

Most notably, manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.

打开APP